Watanabe, Satoshi <br/><br/>
Hepatocyte growth factor inhibits anoikis of pancreatic carcinoma cells through phosphatidylinositol 3-kinase pathway.  [electronic resource] 

 -  Pancreas  May 2011 
 - 608-14 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1536-4828 
<br/><br/><label>Standard No.: </label>10.1097/MPA.0b013e318214fa6c  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Androstadienes--pharmacology<br/>Animals<br/>Anoikis--drug effects<br/>Antibodies--immunology<br/>Blotting, Western<br/>Cadherins--immunology<br/>Cell Adhesion--drug effects<br/>Cell Communication--drug effects<br/>Cell Line, Tumor<br/>Cell Proliferation--drug effects<br/>Cell Survival<br/>Enzyme Inhibitors--pharmacology<br/>Hepatocyte Growth Factor--pharmacology<br/>Humans<br/>Imidazoles--pharmacology<br/>Mice<br/>Mice, Inbred BALB C<br/>Mice, Nude<br/>Pancreatic Neoplasms--drug therapy<br/>Phosphatidylinositol 3-Kinases--metabolism<br/>Phosphoinositide-3 Kinase Inhibitors<br/>Proto-Oncogene Proteins c-akt--metabolism<br/>Pyridines--pharmacology<br/>Signal Transduction--drug effects<br/>Wortmannin<br/>Xenograft Model Antitumor Assays<br/>p38 Mitogen-Activated Protein Kinases--antagonists & inhibitors